Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of levetiracetam in idiopathic generalized epilepsy with primary generalized tonic-clonic seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Idiopathic Generalized Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Generalized Convulsive Epilepsy | Phase 3 | Status: COMPLETED